Last updated on October 2018

Health-economic Impact of Pulse Oximetry Systematic Screening of Critical Congenital Heart Disease in Asymptomatic Newborns


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Critical Congenital Heart Disease
  • Age: - 1 Years
  • Gender: Male or Female

Inclusion Criteria:

BEFORE Period: newborns

  • aged at birth superior or equal to 35 weeks of gestation ( 35+ 0 days weeks of gestation)
  • borned in metropolitan France in involved maternity wards.
  • Asymptomatic before the screening (no respiratory signs, neither collapse or cardiac arrest).

AFTER Period: newborns

  • aged at birth superior or equal to 35 weeks of gestation ( 35+ 0 days weeks of gestation)
  • borned in metropolitan France in involved maternity wards.
  • Asymptomatic before the screening (no respiratory signs, neither collapse or cardiac arrest).
  • With consent done by the 2 parents.
  • Parents covered with the French National health insurance

Exclusion Criteria:

  • Newborns with a prenatally diagnosed congenital cyanotic malformation or any other cyanotic affection.
  • Newborns with a postnatal pre-screening diagnosed congenital cyanotic malformation or any other cyanotic affection.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.